Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher tous les synonymes
Human Monoclonal Glycogen Synthase 1 Primary Antibody pour FACS, ELISA - ABIN969183
Luttjeboer, Harada, Hughes, Johnson, Lilford, Mol: Tubal flushing for subfertility. dans Cochrane database of systematic reviews (Online) 2007
Human Polyclonal Glycogen Synthase 1 Primary Antibody pour IP, IHC - ABIN1043894
Kelsall, Voss, Munro, Cuthbertson, Cohen: R3F, a novel membrane-associated glycogen targeting subunit of protein phosphatase 1 regulates glycogen synthase in astrocytoma cells in response to glucose and extracellular signals. dans Journal of neurochemistry 2011
Insulin-stimulated glycogen synthase (GS) activity was completely ablated during hyperinsulinemic hypoglycemia, and catecholamine signaling via cAMP-dependent protein kinase (PKA) and phosphorylation of inhibiting sites on GS all increased.
Overexpression of GYS1, MIF (Montrer AMH Anticorps), and MYC (Montrer MYC Anticorps) is associated with adverse outcome and poor response to azacitidine in myelodysplastic syndromes and acute myeloid leukemia (Montrer BCL11A Anticorps)
over-expression of muscle glycogen synthase (MGS)was detected in diabetic human kidney
High glycogen synthase 1 expression is associated with myeloid leukemia (Montrer BCL11A Anticorps).
Data suggest that although COOH-terminal dephosphorylation is likely necessary for GS activation, protein kinase Akt-2- (Akt2 (Montrer AKT2 Anticorps))-dependent NH2-terminal dephosphorylation is site for "fine-tuning" insulin (Montrer INS Anticorps)-mediated GS activation in skeletal muscle.
Allosteric regulation and the relationship between phosphorylation and the kinetics of glycogen synthase. [Review]
The present findings demonstrate that physical inactivity-induced insulin (Montrer INS Anticorps) resistance in muscle is associated with lower content/activity of key proteins in glucose transport/phosphorylation and storage.
GYS1 regulation by HIF plays a central role in the hypoxic accumulation of glycogen, and hypoxia also upregulates the expression of UTP:glucose-1-phosphate urydylyltransferase (UGP2 (Montrer UGP2 Anticorps)) and 1,4-alpha glucan branching enzyme (GBE1 (Montrer GBE1 Anticorps))
Exercise unmaskd the effect associated with the GYS1 polymorphism, rendering carriers of this allele less susceptible to the protective effect of exercise on the risk of cardiovascular mortality.
the M416V polymorphism of glycogen synthase 1 gene is not associated with insulin (Montrer INS Anticorps) resistance in type 2 diabetes
Expression analysis revealed that porcine GYS1 was highly expressed in the skeletal muscle and heart
Elevated activity of the mutant glycogen synthase is associated with ineffective regulation via phosphorylation rendering it constitutively active.
the occurrence of the mutated GYS1 allele is influenced by coat colour
The GYS1 mutation was detected in 11 breeds; with prevalence of genetic susceptibility to Type 1 Polysaccharide Storage Myopathy varied from 0.5% to 62.4%.
observed that the two miRNAs, namely, eca-miR (Montrer MYLIP Anticorps)-33a and miR-17, inhibited LDHA (Montrer LDHA Anticorps) and GYS1 expression via binding to the 3' UTR (Montrer UTS2R Anticorps) sequences of each gene
The tissue expression profiles of eGYS1, equine type II hexokinase (eHKII) and muscle-type phosphofructokinase (ePFKM) were determined by real-time PCR and western blot analysis.
Study identified GYS1, encoding skeletal muscle glycogen synthase (GS), as a candidate gene for Polysaccharide storage myopathy; DNA sequence analysis revealed a mutation resulting in an Arg-to-his substitution in a highly conserved region of GS.
The prevalence of a missense mutation of GYS1 in horses with polysaccharide storage myopathy and the prevalence of the mutation based on disease classification are reported.
This GYS1 point mutation appears to cause a gain-of-function of the enzyme and to result in the accumulation of a glycogen-like, less-branched polysaccharide in skeletal muscle.
The GYS1 mutation is an important cause of exertional rhabdomyolysis in UNited Kingdom horse breeds but does not account for all forms of polysaccharide storage myopathy.
These results demonstrate that pharmacological agents that activate GYS1, the main GS subtype found in skeletal muscle, have potential for use as novel treatments for diabetes that improve glucose metabolism in skeletal muscle.
We show that the absence of Epm2aip1 (Montrer EPM2AIP1 Anticorps) in mice impairs allosteric activation of GS by glucose 6-phosphate, decreases hepatic glycogen synthesis, increases liver fat, causes hepatic insulin (Montrer INS Anticorps) resistance, and protects against age-related obesity
Muscle glycogen synthase isoform is responsible for testicular glycogen synthesis: glycogen overproduction induces apoptosis in male germ cells.
Long-term potentiation (LTP (Montrer SCP2 Anticorps)) evoked in the hippocampal CA3 (Montrer CA3 Anticorps)-CA1 (Montrer CA1 Anticorps) synapse was also decreased in behaving GYS1(Nestin (Montrer NES Anticorps)-KO) mice.
Neurodegeneration and functional impairments are associated with glycogen synthase accumulation in the mouse model of Lafora disease.
Overexpression of glycogen synthase in skeletal muscle results in less branched glycogen.
The endogenous glycogen synthase in extracts from mouse brain bound specifically to SAPK2b/p38b (Montrer MAPK11 Anticorps) & was phosphorylated at residues Ser644, Ser652, Thr718 and Ser724.
JNK signaling regulates the phosphorylation state of several kinases in skeletal muscle. JNK activation is unlikely to be the major mechanism by which contractile activity increases glycogen synthase activity in skeletal muscle.
the GYS1 gene is not essential for strenuous exercise and has relatively little effect on endurance in mice
The protein encoded by this gene catalyzes the addition of glucose monomers to the growing glycogen molecule through the formation of alpha-1,4-glycoside linkages. Mutations in this gene are associated with muscle glycogen storage disease. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
glycogen [starch] synthase, muscle
, glycogen synthase 1 (muscle)
, glycogen synthase 3, brain